• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Bearish Monday For Marijuana Stocks - AusCann Group Holdings, Target Group Among Top Gainers

    4/15/24 4:30:05 PM ET
    $ACB
    $CARA
    $CGC
    $GENE
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACB alert in real time by email

    GAINERS:

    • Target Group (OTC:CBDY) shares closed up 26.37% at $0.01
    • Greenlane Hldgs (NASDAQ:GNLN) shares closed up 17.52% at $0.70
    • Mexco Energy (AMEX:MXC) shares closed up 16.17% at $16.38
    • Zoned Props (OTC:ZDPY) shares closed up 16.05% at $0.60
    • Pharmadrug (OTC:LMLLF) shares closed up 11.25% at $0.03
    • Village Farms Intl (NASDAQ:VFF) shares closed up 10.24% at $1.39
    • CLS Holdings USA (OTC:CLSH) shares closed up 10.22% at $0.06
    • Affinor Growers (OTC:RSSFF) shares closed up 10.00% at $0.06
    • Psychemedics (NASDAQ:PMD) shares closed up 9.28% at $2.65
    • Urban-gro (NASDAQ:UGRO) shares closed up 4.27% at $1.71
    • OrganiGram Holdings (NASDAQ:OGI) shares closed up 3.61% at $1.88
    • cbdMD (AMEX:YCBD) shares closed up 3.46% at $0.95
    • C21 Investments (OTC:CXXIF) shares closed up 3.36% at $0.32

    LOSERS:

    • AusCann Group Holdings (OTC:ACNNF) shares closed down 77.68% at $0.00
    • CNBX Pharmaceuticals (OTC:CNBX) shares closed down 21.48% at $0.01
    • Blueberries Medical (OTC:BBRRF) shares closed down 21.23% at $0.01
    • Indiva (OTC:NDVAF) shares closed down 18.68% at $0.04
    • Elixinol Wellness (OTC:ELLXF) shares closed down 15.63% at $0.00
    • 1933 Industries (OTC:TGIFF) shares closed down 13.48% at $0.01
    • Canopy Gwth (NASDAQ:CGC) shares closed down 11.28% at $6.98
    • CordovaCann (OTC:LVRLF) shares closed down 9.32% at $0.07
    • Body and Mind (OTC:BMMJ) shares closed down 8.59% at $0.07
    • Leafbuyer Techs (OTC:LBUY) shares closed down 7.75% at $0.03
    • Cansortium (OTC:CNTMF) shares closed down 7.45% at $0.18
    • Cara Therapeutics (NASDAQ:CARA) shares closed down 7.08% at $0.71
    • 22nd Century Group (NASDAQ:XXII) shares closed down 6.55% at $1.61
    • Genetic Technologies (NASDAQ:GENE) shares closed down 6.35% at $3.27
    • Aurora Cannabis (NASDAQ:ACB) shares closed down 5.61% at $6.28
    • SNDL (NASDAQ:SNDL) shares closed down 4.50% at $1.92
    • Cannabix Technologies (OTC:BLOZF) shares closed down 3.49% at $0.17
    • Rivernorth Opps Fund (NYSE:RIV) shares closed down 3.17% at $11.32
    • SOL Glb Inv (OTC:SOLCF) shares closed down 3.15% at $0.02

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACB
    $CARA
    $CGC
    $GENE

    CompanyDatePrice TargetRatingAnalyst
    Aurora Cannabis Inc.
    $ACB
    1/27/2026Buy
    Canaccord Genuity
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Canopy Growth Corporation
    $CGC
    11/10/2025Sell → Hold
    The Benchmark Company
    SNDL Inc.
    $SNDL
    9/3/2025$5.00Buy
    Alliance Global Partners
    Aurora Cannabis Inc.
    $ACB
    12/11/2024Buy
    TD Cowen
    SNDL Inc.
    $SNDL
    7/17/2024Speculative Buy
    Canaccord Genuity
    Organigram Global Inc.
    $OGI
    7/17/2024Speculative Buy
    Canaccord Genuity
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$6.00 → $1.00Buy → Hold
    Stifel
    More analyst ratings

    $ACB
    $CARA
    $CGC
    $GENE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

    Special Meeting to Approve Acquisition of Sanity Group GmbH Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that it has mailed and filed a management information circular (the "Circular") and related materials (the "Meeting Materials") for its annual and special meeting (the "Meeting") of the holders of its common shares (the "Shareholders") to be held on March 30, 2026. The Circular is available under Organigram's profile on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. In addition to routine annual business to be conducted, Shareholders at the Meeting will be asked to consider and vote u

    3/10/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity

    FAST™-powered SHRED Shotz extends the SHRED brand into shot-sized beverages Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1 is pleased to announce the launch of SHRED Shotz, a compact, single-serve 65ml cannabis beverage powered by FAST™, Organigram's fast-acting nanoemulsion technology platform designed to deliver a 15-minute onset2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305717369/en/ This launch reflects Organigram's focus on differentiated innovation while leveraging the scale of SHRED, one of the Company's best-known brands. SHRED sur

    3/5/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Greenlane Posts Investor Overview on Company Website

    BOCA RATON, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN), a company with a Berachain-focused Digital Asset Treasury ("DAT"), today announced the posting of an investor overview document titled "Investor Overview: Greenlane Holdings and the Berachain Digital Asset Treasury Strategy" (the "Investor Overview") on the Company's website. The Investor Overview provides background on the Company's Berachain-focused digital asset treasury strategy, including the Company's publicly reported BERA holdings, staking activity, and validator deployment, as well as an overview of the Berachain ecosystem. All Company-specific data referenc

    3/3/26 9:23:53 AM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    $ACB
    $CARA
    $CGC
    $GENE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Decker Thomas H sold $70,375 worth of MXC COMMON STOCK (5,000 units at $14.07), decreasing direct ownership by 21% to 18,400 units (SEC Form 4)

    4 - MEXCO ENERGY CORP (0000066418) (Issuer)

    3/9/26 7:53:22 PM ET
    $MXC
    Oil & Gas Production
    Energy

    SEC Form 3 filed by new insider Hitchcock Jason

    3 - Greenlane Holdings, Inc. (0001743745) (Issuer)

    3/6/26 4:55:35 PM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    Chief Executive Officer Mongeau Luc sold $9,951 worth of shares (9,376 units at $1.06), decreasing direct ownership by 1% to 802,992 units (SEC Form 4)

    4 - Canopy Growth Corp (0001737927) (Issuer)

    2/12/26 7:53:43 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $CARA
    $CGC
    $GENE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Organigram Global

    Canaccord Genuity initiated coverage of Organigram Global with a rating of Buy

    1/27/26 9:29:20 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canaccord Genuity initiated coverage on Aurora Cannabis

    Canaccord Genuity initiated coverage of Aurora Cannabis with a rating of Buy

    1/27/26 9:29:20 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Canopy Growth upgraded by The Benchmark Company

    The Benchmark Company upgraded Canopy Growth from Sell to Hold

    11/10/25 8:33:16 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $CARA
    $CGC
    $GENE
    SEC Filings

    View All

    $ACB
    $CARA
    $CGC
    $GENE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $ACB
    $CARA
    $CGC
    $GENE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    SEC Form 6-K filed by Organigram Global Inc.

    6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)

    3/9/26 5:14:50 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    urban-gro Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - urban-gro, Inc. (0001706524) (Filer)

    3/9/26 9:00:20 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    SEC Form N-CSRS filed by RiverNorth Opportunities Fund Inc.

    N-CSRS - RIVERNORTH OPPORTUNITIES FUND, INC. (0001501072) (Filer)

    3/6/26 11:03:57 AM ET
    $RIV
    Finance Companies
    Finance

    Chief Executive Officer Mongeau Luc bought $49,994 worth of shares (27,469 units at $1.82), increasing direct ownership by 3% to 812,368 units (SEC Form 4)

    4 - Canopy Growth Corp (0001737927) (Issuer)

    9/23/25 4:15:11 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: Chief Executive Officer Degiglio Michael A bought $30,150 worth of shares (25,000 units at $1.21), increasing direct ownership by 0.26% to 9,783,127 units (SEC Form 4)

    4/A - Village Farms International, Inc. (0001584549) (Issuer)

    6/3/25 9:00:14 PM ET
    $VFF

    Chief Financial Officer Degiglio Michael A bought $30,150 worth of shares (25,000 units at $1.21), increasing direct ownership by 0.26% to 9,783,127 units (SEC Form 4)

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    6/2/25 6:17:22 AM ET
    $VFF

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $CARA
    $CGC
    $GENE
    Financials

    Live finance-specific insights

    View All

    Village Farms International to Report Q4 and Full Year 2025 Results on March 12, 2026

    VANCOUVER, British Columbia, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ:VFF) today announced it will host a conference call to discuss its fourth quarter and full year 2025 financial results on Thursday, March 12, 2026, at 8:30 a.m. ET. Participants can access the conference call via a webcast at Village Farms Fourth Quarter 2025 Conference Call Webcast or on the Company website at Village Farms - Events. Participants wanting to access the conference call by telephone must register in advance at Village Farms Fourth Quarter 2025 Conference Call Registration to receive telephone dial-in information. The live question and a

    2/26/26 4:30:00 PM ET
    $VFF

    22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results

    Balance sheet strength, ended 2025 with $7.1 million in cash and debt free, supports transition to growth Continued VLN® commercial expansion drives shift toward higher margin proprietary branded products MOCKSVILLE, N.C., Feb. 20, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced select, preliminary and unaudited financial results and operating metrics for the fourth quarter and full year ended December 31, 2025. The company anticipates releasing fourth quarter and full year 2025 earnings on or before March

    2/20/26 4:15:00 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    SNDL to Report Fourth Quarter 2025 and Full Year 2025 Financial Results on March 12, 2026

    EDMONTON, Alberta, Feb. 19, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ:SNDL, CSE:SNDL) ("SNDL") announced today that it will release its fourth quarter and full year 2025 financial results for the period ended December 31, 2025, before markets open on Thursday, March 12, 2026. Following the release of its fourth quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on March 12, 2026. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/aps8jm4e ABOUT SNDL INC.  SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), through its wholly owned subsidiaries, is one of the largest vertically integr

    2/19/26 4:30:00 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $CARA
    $CGC
    $GENE
    Leadership Updates

    Live Leadership Updates

    View All

    Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

    Special Meeting to Approve Acquisition of Sanity Group GmbH Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that it has mailed and filed a management information circular (the "Circular") and related materials (the "Meeting Materials") for its annual and special meeting (the "Meeting") of the holders of its common shares (the "Shareholders") to be held on March 30, 2026. The Circular is available under Organigram's profile on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. In addition to routine annual business to be conducted, Shareholders at the Meeting will be asked to consider and vote u

    3/10/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Greenlane Provides Digital Asset Treasury Update: Completes Deployment of Approximately 50 Million Units of BERA

    Total holdings of approximately 70.4 million units of BERA as of February 27, 2026 Up to 50 million units of BERA deployed into validator infrastructure across multiple operators Jason Hitchcock appointed Chief Executive Officer to advance DAT strategy BOCA RATON, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN), a company with a Berachain-focused Digital Asset Treasury ("DAT"), is providing an update on its holdings of units of BERA and deployment activity. Digital Asset Treasury Holdings Update As of February 27, 2026, the Company held approximately 70.4 million units of BERA1. Since the Company's last treasury update on

    3/3/26 7:30:00 AM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    Greenlane Appoints Jason Hitchcock as Chief Executive Officer to Advance Digital Asset Treasury Strategy

    BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN) today announced the appointment of Jason Hitchcock as its Chief Executive Officer, effective immediately. Mr. Hitchcock is a technology executive with over 15 years of experience building and scaling revenue engines across SaaS, blockchain infrastructure, and decentralized finance. He joins Greenlane as the Company continues to execute its Berachain-focused Digital Asset Treasury ("DAT") strategy, combining disciplined capital allocation with active ecosystem participation through validator operations, staking, and liquidity provisioning. Technology Leadership and Ent

    2/18/26 8:00:00 AM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    $ACB
    $CARA
    $CGC
    $GENE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/12/24 5:15:40 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Psychemedics Corporation

    SC 13G/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/6/24 9:18:20 PM ET
    $PMD
    Medical Specialities
    Health Care

    $ACB
    $CARA
    $CGC
    $GENE
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary